Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 30, Number 9—September 2024
Dispatch

Epidemiology of Lyme Disease Diagnoses among Older Adults, United States, 2016–20191

Amy M. Schwartz, Christina A. Nelson, and Alison F. HinckleyComments to Author 
Author affiliations: Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (A.M. Schwartz, C.A. Nelson, A.F. Hinckley); University of Iowa, Iowa City, Iowa, USA (A.M. Schwartz)

Main Article

Figure 2

Lyme disease incidence for older adults, United States, 2016–2019. Results according to age group, sex, and geographic category of Lyme disease endemicity based on Medicare fee-for-service beneficiary data (A,C,F) and from US Census surveillance data (B,D,F). A,B) Disease incidence for men and women in high-incidence states. C,D) Disease incidence for men and women in neighboring states. E,F) Disease incidence for men and women in low-incidence states. Incidence calculated as diagnoses/100,000 beneficiaries in Medicare fee-for-service plans or cases/100,000 population among each subcategory. Scales for each y-axis differ substantially to underscore overall age-related incidence patterns but do not permit direct comparison of the magnitude of Lyme disease between systems or geographic categories.

Figure 2. Lyme disease incidence for older adults, United States, 2016–2019. Results according to age group, sex, and geographic category of Lyme disease endemicity based on Medicare fee-for-service beneficiary data (A,C,F) and from US Census surveillance data (B,D,F). A,B) Disease incidence for men and women in high-incidence states. C,D) Disease incidence for men and women in neighboring states. E,F) Disease incidence for men and women in low-incidence states. Incidence calculated as diagnoses/100,000 beneficiaries in Medicare fee-for-service plans or cases/100,000 population among each subcategory. Scales for each y-axis differ substantially to underscore overall age-related incidence patterns but do not permit direct comparison of the magnitude of Lyme disease between systems or geographic categories.

Main Article

1Preliminary results from this study were presented at the International Conference on Emerging Infectious Diseases; August 7–10, 2022, Atlanta, Georgia, USA.

Page created: August 13, 2024
Page updated: August 13, 2024
Page reviewed: August 13, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external